FDA Fast-Tracks Licensure of MF59 Adjuvanted Influenza Vaccine
By Barbara Loe Fisher
Published September 16, 2015
On Sept. 15, 2015 FDA advisors voted to fast-track MF59 adjuvanted influenza vaccine, despite safety concerns and the higher number of adverse reactions to Fluad vaccine.
Read more
ANOTHER Epic Fail for Influenza Vaccine
By Barbara Loe Fisher
Published January 07, 2015
Flu vaccine effectiveness is measured from 0-62 percent as U.S. public health officials admit that the ineffective influenza vaccine is once again an epic fail.
Read more
FDA Approves Experimental H5N1 Bird Flu Vaccine with Reactive AS03 Adjuvant for U.S. Stockpile
By Patrice La Vigne
Published December 09, 2013
How did squalene based bird flu vaccine make it into the U.S. Vaccine Stockpile? NVIC exposes safety issues associated the “oil-in-water” adjuvant present in this vaccine that has never before been licensed for use in the U.S.
Read more
Stephanie Christner Appointed to Serve on FDA’s Vaccine Advisory Committee
By NVIC Staff
Published November 11, 2013
NVIC Board Member Dr. Stephanie Christner, a mother whose baby died after vaccine reactions, has been appointed to an FDA committee that evaluates vaccine safety and effectiveness data.
Read more
